In 2024, Abbott Laboratories completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Abbott Laboratories has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2024, the total operational greenhouse gas (GHG) emissions of Abbott Laboratories amounted to 974,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Abbott Laboratories decreased by 0.1%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2024, the total Scope 1 emissions of Abbott Laboratories were 502,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2018, Abbott Laboratories's Scope 1 emissions have decreased by 6.52%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Abbott Laboratories's Scope 1 emissions remained relatively stable, indicating that Abbott Laboratories's emissions have plateaued with no significant change in its operational footprint.
In 2024, Abbott Laboratories reported Scope 2 greenhouse gas (GHG) emissions of 393,000 tCOâ‚‚e using the market-based method, and 472,000 tCOâ‚‚e using the location-based method.
Since 2018, Abbott Laboratories's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 10.27%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), Abbott Laboratories's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Abbott Laboratories 's emissions have plateaued with no significant change in its energy consumption footprint.
In 2024, Abbott Laboratories reported its Scope 2 emissions using the market-based method and using the location-based method.
In 2024, Abbott Laboratories reported 9,971,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Abbott Laboratories includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
In 2024, Abbott Laboratories reported total Scope 3 emissions of 9,971,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 94.48% of these emissions originated from upstream activities such as purchased goods and capital goods, while 5.52% came from downstream activities like product use, distribution, and end-of-life treatment.
Compared to the previous year (2023), Abbott Laboratories's Scope 3 emissions remained relatively stable, indicating that Abbott Laboratories 's emissions have plateaued with no significant change in its value chain footprint.
In 2024, Abbott Laboratories reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to Abbott Laboratories's Scope 3 emissions were:
In 2024, Abbott Laboratories reported a total carbon footprint of 10,945,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.97% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Abbott Laboratories's total carbon footprint was Scope 3 emissions, accounting for 91.1% of the company's total carbon footprint, followed by Scope 1 emissions at 4.59%.